-49%

est. 2Y upside i

HealthcareSeries A

Avelios is a modern and modular hospital information system bringing together documentation, administration, patient portals, AI solutions and more.

Rank

#55

Sector

HealthTech

Est. Liquidity

~4Y

Data Quality

Data: High

Avelios presents a strong upside opportunity driven by its strategic partnership with SAP, which positions it to capitalize on a significant market void.

Last updated: March 10, 2026

Bull (40%)+400%

Avelios successfully leverages its strategic partnership and investment from SAP to capture a significant portion of the market vacated by SAP's IS-H exit, expanding rapidly across Germany and potentially into other European markets. Its modular, AI-native platform becomes the preferred choice for hospitals seeking modern, integrated solutions, driving revenue to over $150M by 2028 and justifying a $250M+ valuation at 5x current valuation.

Base (35%)+100%

Avelios continues to grow steadily, securing additional key hospital customers in Germany and solidifying its position as a strong alternative in the transforming HIS market. While facing ongoing competition from incumbents like Epic and Cerner, the SAP partnership provides a stable pipeline. Revenue reaches approximately $60M-$70M by 2028, leading to a valuation of around $100M-$120M, a 2x return.

Bear (25%)-80%

Despite the SAP partnership, Avelios struggles to scale effectively against entrenched incumbents and new competitors, or faces unforeseen regulatory hurdles. Growth slows significantly, and the company fails to secure sufficient follow-on funding at an attractive valuation. A down round or acquisition at a significantly reduced valuation (e.g., $10M) wipes out most common stock value due to liquidation preferences.

Est. time to liquidity~3.5 years

Preference Stack Risk

severe

Funding Intensity

67%

Investors hold $33M in liquidation preferences ahead of common stock, representing 66.7% of the current $50M valuation.

Dilution Risk

high

As a Series A company with high funding intensity, significant future dilution from subsequent funding rounds is likely before a liquidity event.

Secondary Liquidity

none

No information available regarding active secondary markets or tender offers for Avelios equity.

Questions to Ask at the Interview

Strategic questions based on Avelios's data — designed to show you've done your homework.

  • 1

    “Given the strategic partnership and investment from SAP, how is Avelios planning to differentiate its offering from other solutions that SAP's exiting customers might consider, and what are the key milestones for the joint platform development over the next 12-18 months?”

  • 2

    “With $29M in revenue and a TAM of $116.8B, what is Avelios's strategy for rapidly expanding market penetration beyond Germany, especially considering the high regulatory barriers in new geographies?”

  • 3

    “As a Series A company with significant funding and a severe preference stack, how is Avelios thinking about the path to a liquidity event for employees, and what are the company's plans for managing potential dilution in future funding rounds?”

Community

Valuation Sentiment

Our model estimates -49% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.